Trial
NCT06169280
Repeated Neural Stem Cell Based Virotherapy for Newly Diagnosed High Grade Glioma
Phase ISUSPENDEDSAFETYConfidence: MEDIUM
Sponsor
Northwestern University
Collaborators
—
Condition
Glioma, Malignant
Intervention
NSC-CRAd-S-pk7
Why stopped
Safety issues
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-30